It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis

Jean Michel Saad; Ahmed Ibrahim Ahmed; Dixitha Anugula; Yushui Han; Moath Said Alfawara; Mouaz H. Al-Mallah

doi:10.14797/mdcvj.1072

It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis

Methodist DeBakey Cardiovascular Journal

Volume 18 (2022): Issue 2

By: Jean Michel Saad , Ahmed Ibrahim Ahmed , Dixitha Anugula , Yushui Han , Moath Said Alfawara and Mouaz H. Al-Mallah

Open Access

|Mar 2022

Arno S, Cowger J. The genetics of cardiac amyloidosis. Heart Fail Rev. 2021 Sep 13. DOI: 10.1007/s10741-021-10164-z
Open DOI Search in Google Scholar Back to article
Child JS, Levisman JA, Abbasi AS, MacAlpin RN. Echocardiographic manifestations of infiltrative cardiomyopathy. A report of seven cases due to amyloid. Chest. 1976 Dec;70(6):726-31. DOI: 10.1378/chest.70.6.726
Open DOI Search in Google Scholar Back to article
Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circ Cardiovasc Imaging. 2021 Jul;14(7):e000029. DOI: 10.1161/HCI.0000000000000029
Open DOI Search in Google Scholar Back to article
Falk RH, Quarta CC. Echocardiography in cardiac amyloidosis. Heart Fail Rev. 2015 Mar;20(2):125-31. DOI: 10.1007/s10741-014-9466-3
Open DOI Search in Google Scholar Back to article
Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol. 2016 Sep 20;68(12):1323-41. DOI: 10.1016/j.jacc.2016.06.053
Open DOI Search in Google Scholar Back to article
Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016 Jun 25;387(10038):2641-2654. DOI: 10.1016/S0140-6736(15)01274-X
Open DOI Search in Google Scholar Back to article
Agrawal T, Nagueh SF. Echocardiographic assessment of cardiac amyloidosis. Heart Fail Rev. 2021 Aug 30. DOI: 10.1007/s10741-021-10165-y
Open DOI Search in Google Scholar Back to article
Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005 Aug;79(4):319-28. DOI: 10.1002/ajh.20381
Open DOI Search in Google Scholar Back to article
Nochioka K, Quarta CC, Claggett B, et al. Left atrial structure and function in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1128-1137. DOI: 10.1093/ehjci/jex097
Open DOI Search in Google Scholar Back to article
Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985 Oct;6(4):737-43. DOI: 10.1016/s0735-1097(85)80475-7
Open DOI Search in Google Scholar Back to article
Quarta CC, Solomon SD, Uraizee I, et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014 May 6;129(18):1840-9. DOI: 10.1161/CIRCULATIONAHA.113.006242
Open DOI Search in Google Scholar Back to article
González-López E, Gagliardi C, Dominguez F, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. Eur Heart J. 2017 Jun 21;38(24):1895-1904. DOI: 10.1093/eurheartj/ehx043
Open DOI Search in Google Scholar Back to article
Habib G, Bucciarelli-Ducci C, Caforio ALP, et al. Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1090-1121. DOI: 10.1093/ehjci/jex034
Open DOI Search in Google Scholar Back to article
Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1989 Apr;13(5):1017-26. DOI: 10.1016/0735-1097(89)90254-4
Open DOI Search in Google Scholar Back to article
Koyama J, Ray-Sequin PA, Davidoff R, Falk RH. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol. 2002 May 1;89(9):1067-71. DOI: 10.1016/s0002-9149(02)02277-4
Open DOI Search in Google Scholar Back to article
Austin BA, Duffy B, Tan C, Rodriguez ER, Starling RC, Desai MY. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol. 2009 May 15;103(10):1429-33. DOI: 10.1016/j.amjcard.2009.01.361
Open DOI Search in Google Scholar Back to article
Knight DS, Giulia Z, William B, et al. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC Cardiovasc Imaging. 2019 May;12(5):823-833. DOI: 10.1016/j.jcmg.2018.02.016
Open DOI Search in Google Scholar Back to article
Tsang W, Lang RM. Echocardiographic evaluation of cardiac amyloid. Curr Cardiol Rep. 2010 May;12(3):272-6. DOI: 10.1007/s11886-010-0108-7
Open DOI Search in Google Scholar Back to article
Tendler A, Helmke S, Teruya S, Alvarez J, Maurer MS. The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis. Amyloid. 2015 Mar;22(1):61-6. DOI: 10.3109/13506129.2014.994202
Open DOI Search in Google Scholar Back to article
Arenja N, Fritz T, Andre F, et al. Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1414-1422. DOI: 10.1093/ehjci/jew324
Open DOI Search in Google Scholar Back to article
Milani P, Dispenzieri A, Scott CG, et al. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis. Circ Cardiovasc Imaging. 2018 May;11(5):e006588. DOI: 10.1161/CIRCIMAGING.117.006588
Open DOI Search in Google Scholar Back to article
Pagourelias ED, Mirea O, Duchenne J, et al. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters. Circ Cardiovasc Imaging. 2017 Mar;10(3):e005588. DOI: 10.1161/CIRCIMAGING.116.005588
Open DOI Search in Google Scholar Back to article
Buss SJ, Emami M, Mereles D, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol. 2012 Sep 18;60(12):1067-76. DOI: 10.1016/j.jacc.2012.04.043
Open DOI Search in Google Scholar Back to article
Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003 May 20;107(19):2446-52. DOI: 10.1161/01.CIR.0000068313.67758.4F
Open DOI Search in Google Scholar Back to article
Senapati A, Sperry BW, Grodin JL, et al. Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart. 2016 May 15;102(10):748-54. DOI: 10.1136/heartjnl-2015-308657
Open DOI Search in Google Scholar Back to article
Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012 Oct;98(19):1442-8. DOI: 10.1136/heartjnl-2012-302353
Open DOI Search in Google Scholar Back to article
Liu D, Hu K, Niemann M, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013 Nov;6(6):1066-72. DOI: 10.1161/CIRCIMAGING.113.000683
Open DOI Search in Google Scholar Back to article
Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 2010 Apr;3(4):333-42. DOI: 10.1016/j.jcmg.2009.11.013
Open DOI Search in Google Scholar Back to article
Pennell DJ. Cardiovascular magnetic resonance: twenty-first century solutions in cardiology. Clin Med (Lond). May-Jun 2003;3(3):273-8. DOI: 10.7861/clinmedicine.3-3-273
Open DOI Search in Google Scholar Back to article
Martinez-Naharro A, Treibel TA, Abdel-Gadir A, et al. Magnetic Resonance in Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2017 Jul 25;70(4):466-477. DOI: 10.1016/j.jacc.2017.05.053
Open DOI Search in Google Scholar Back to article
Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005 Jan 18;111(2):186-93. DOI: 10.1161/01.CIR.0000152819.97857.9D
Open DOI Search in Google Scholar Back to article
Fontana M, Chung R, Hawkins PN, Moon JC. Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev. 2015 Mar;20(2):133-44. DOI: 10.1007/s10741-014-9470-7
Open DOI Search in Google Scholar Back to article
Kwong RY, Heydari B, Abbasi S, et al. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function. Am J Cardiol. 2015 Aug 15;116(4):622-9. DOI: 10.1016/j.amjcard.2015.05.021
Open DOI Search in Google Scholar Back to article
Fontana M, Treibel TA, Martinez-Naharro A, et al. A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid. BMC Med Imaging. 2017 Jan 7;17(1):3. DOI: 10.1186/s12880-016-0173-5
Open DOI Search in Google Scholar Back to article
Fontana M, Pica S, Reant P, et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015 Oct 20;132(16):1570-9. DOI: 10.1161/CIRCULATIONAHA.115.016567
Open DOI Search in Google Scholar Back to article
Zhao L, Tian Z, Fang Q. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016 Jun 7;16:129. DOI: 10.1186/s12872-016-0311-6
Open DOI Search in Google Scholar Back to article
Dungu JN, Valencia O, Pinney JH, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014 Feb;7(2):133-42. DOI: 10.1016/j.jcmg.2013.08.015
Open DOI Search in Google Scholar Back to article
Bollée G, Guery B, Joly D, et al. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin J Am Soc Nephrol. 2008 Mar;3(2):375-81. DOI: 10.2215/CJN.02470607
Open DOI Search in Google Scholar Back to article
Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. DOI: 10.1186/s12968-017-0389-8
Open DOI Search in Google Scholar Back to article
Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013 Oct 14;15(1):92. DOI: 10.1186/1532-429X-15-92
Open DOI Search in Google Scholar Back to article
Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2013 Jan 1;6(1):34-9. DOI: 10.1161/CIRCIMAGING.112.978627
Open DOI Search in Google Scholar Back to article
Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013 Apr;6(4):488-97. DOI: 10.1016/j.jcmg.2012.11.013
Open DOI Search in Google Scholar Back to article
Fontana M, Banypersad SM, Treibel TA, et al. Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging. 2014 Feb;7(2):157-65. DOI: 10.1016/j.jcmg.2013.10.008
Open DOI Search in Google Scholar Back to article
Martinez-Naharro A, Abdel-Gadir A, Treibel TA, et al. CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy. JACC Cardiovasc Imaging. 2018 Jan;11(1):152-154. DOI: 10.1016/j.jcmg.2017.02.012
Open DOI Search in Google Scholar Back to article
Banypersad SM, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015 Jan 21;36(4):244-51. DOI: 10.1093/eurheartj/ehu444
Open DOI Search in Google Scholar Back to article
Martinez-Naharro A, Kotecha T, Norrington K, et al. Native T1 and extracellular volume in transthyretin amyloidosis. JACC Cardiovasc Imaging. 2019 May;12(5):810-819. DOI: 10.1016/j.jcmg.2018.02.006
Open DOI Search in Google Scholar Back to article
Raina S, Lensing SY, Nairooz RS, et al. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 Nov;9(11):1267-1277. DOI: 10.1016/j.jcmg.2016.01.036
Open DOI Search in Google Scholar Back to article
Legou F, Tacher V, Damy T, et al. Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging. Diagn Interv Imaging. 2017 Feb;98(2):125-132. DOI: 10.1016/j.diii.2016.08.007
Open DOI Search in Google Scholar Back to article
Wassmuth R, Abdel-Aty H, Bohl S, Schulz-Menger J. Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. Eur Radiol. 2011 Aug;21(8):1643-50. DOI: 10.1007/s00330-011-2109-3
Open DOI Search in Google Scholar Back to article
Kotecha T, Martinez-Naharro A, Treibel TA, et al. Myocardial Edema and Prognosis in Amyloidosis. J Am Coll Cardiol. 2018 Jun 26;71(25):2919-2931. DOI: 10.1016/j.jacc.2018.03.536
Open DOI Search in Google Scholar Back to article
Saad JM, Ahmed AI, Han Y, Saeed S, Pournazari P, Al-Mallah MH. 99m Technetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions. Heart Fail Rev. 2021 Oct 28. DOI: 10.1007/s10741-021-10174-x
Open DOI Search in Google Scholar Back to article
Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14;133(24):2404-12. DOI: 10.1161/CIRCULATIONAHA.116.021612
Open DOI Search in Google Scholar Back to article
Ali A, Turner DA, Rosenbush SW, Fordham EW. Bone scintigram in cardiac amyloidosis: a case report. Clin Nucl Med. 1981 Mar;6(3):105-8. DOI: 10.1097/00003072-198103000-00003
Open DOI Search in Google Scholar Back to article
Sobol SM, Brown JM, Bunker SR, Patel J, Lull RJ. Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy. Am Heart J. 1982 Apr;103(4 Pt 1):563-6. DOI: 10.1016/0002-8703(82)90344-1
Open DOI Search in Google Scholar Back to article
Shih WJ, DeLand FH, Domstad PA, Stahr BJ, Powell RD, Yoneda K. Scintigraphic findings in primary amyloidosis of the heart and stomach. Clin Nucl Med. 1985 Jul;10(7):466-7. DOI: 10.1097/00003072-198507000-00003
Open DOI Search in Google Scholar Back to article
Li CK, Rabinovitch MA, Juni JE, et al. Scintigraphic characterization of amyloid cardiomyopathy. Clin Nucl Med. 1985 Mar;10(3):156-9. DOI: 10.1097/00003072-198503000-00004
Open DOI Search in Google Scholar Back to article
Janssen S, van Rijswijk MH, Piers DA, de Jong GM. Soft-tissue uptake of 99mTc-diphosphonate in systemic AL amyloidosis. Eur J Nucl Med. 1984;9(12):538-41. DOI: 10.1007/BF00256851
Open DOI Search in Google Scholar Back to article
Perugini E, Guidalotti PL, Salvi F, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84. DOI: 10.1016/j.jacc.2005.05.073
Open DOI Search in Google Scholar Back to article
Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201. DOI: 10.1161/CIRCIMAGING.112.000132
Open DOI Search in Google Scholar Back to article
Galat A, Rosso J, Guellich A, et al. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid. 2015;22(4):210-20. DOI: 10.3109/13506129.2015.1072089
Open DOI Search in Google Scholar Back to article
Rapezzi C, Gagliardi C, Milandri A. Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis. J Nucl Cardiol. 2019 Oct;26(5):1638-1641. DOI: 10.1007/s12350-018-1235-6
Open DOI Search in Google Scholar Back to article
Coutinho MCA, Cortez-Dias N, Cantinho G, et al. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease. Amyloid. 2020 Sep;27(3):174-183. DOI: 10.1080/13506129.2020.1744553
Open DOI Search in Google Scholar Back to article
Pilebro B, Suhr OB, Näslund U, Westermark P, Lindqvist P, Sundström T. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Ups J Med Sci. 2016;121(1):17-24. DOI: 10.3109/03009734.2015.1122687
Open DOI Search in Google Scholar Back to article
Musumeci MB, Cappelli F, Russo D, et al. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2020 Jun;13(6):1314-1321. DOI: 10.1016/j.jcmg.2019.10.015
Open DOI Search in Google Scholar Back to article
Takasone K, Katoh N, Takahashi Y, et al. Non-invasive detection and differentiation of cardiac amyloidosis using 99m Tc-pyrophosphate scintigraphy and 11 C-Pittsburgh compound B PET imaging. Amyloid. 2020 Dec;27(4):266-274. DOI: 10.1080/13506129.2020.1798223
Open DOI Search in Google Scholar Back to article
Pilebro B, Arvidsson S, Lindqvist P, et al. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR). J Nucl Cardiol. 2018 Feb;25(1):240-248. DOI: 10.1007/s12350-016-0638-5
Open DOI Search in Google Scholar Back to article
Castano A, Haq M, Narotsky DL, et al. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 Nov 1;1(8):880-889. DOI: 10.1001/jamacardio.2016.2839
Open DOI Search in Google Scholar Back to article
Hutt DF, Fontana M, Burniston M, et al. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1344-1350. DOI: 10.1093/ehjci/jew325
Open DOI Search in Google Scholar Back to article
Rapezzi C, Quarta CC, Guidalotti PL, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011 Jun;4(6):659-70. DOI: 10.1016/j.jcmg.2011.03.016
Open DOI Search in Google Scholar Back to article
Vranian MN, Sperry BW, Hanna M, et al. Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes. J Nucl Cardiol. 2018 Aug;25(4):1247-1256. DOI: 10.1007/s12350-016-0768-9
Open DOI Search in Google Scholar Back to article
Sperry BW, Sato K, Phelan D, et al. Regional Variability in Longitudinal Strain Across Vendors in Patients With Cardiomyopathy Due to Increased Left Ventricular Wall Thickness. Circ Cardiovasc Imaging. 2019 Aug;12(8):e008973. DOI: 10.1161/CIRCIMAGING.119.008973
Open DOI Search in Google Scholar Back to article
Saeed S, Saad JM, Ahmed AI, Han Y, Al-Mallah MH. The utility of positron emission tomography in cardiac amyloidosis. Heart Fail Rev. 2021 Nov 7. DOI: 10.1007/s10741-021-10183-w
Open DOI Search in Google Scholar Back to article
Antoni G, Lubberink M, Estrada S, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med. 2013 Feb;54(2):213-20. DOI: 10.2967/jnumed.111.102053
Open DOI Search in Google Scholar Back to article
Lee S, Lee ES, Choi H, et al. 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging. 2015 Jan;8(1):50-59. DOI: 10.1016/j.jcmg.2014.09.018
Open DOI Search in Google Scholar Back to article
Rosengren S, Skibsted Clemmensen T, Tolbod L, et al. Diagnostic Accuracy of [11 C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2020 Jun;13(6):1337-1347. DOI: 10.1016/j.jcmg.2020.02.023
Open DOI Search in Google Scholar Back to article
Choi SR, Schneider JA, Bennett DA, et al. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. Jan-Mar 2012;26(1):8-16. DOI: 10.1097/WAD.0b013e31821300bc
Open DOI Search in Google Scholar Back to article
Park M, Padera RF, Belanger A, et al. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug;8(8):10.1161/CIRCIMAGING.114.002954 e002954. DOI: 10.1161/CIRCIMAGING.114.002954
Open DOI Search in Google Scholar Back to article
Law WP, Wang WYS, Moore PT, Mollee PN, Ng ACT. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study. J Nucl Med. 2016 Nov;57(11):1733-1739. DOI: 10.2967/jnumed.115.169870
Open DOI Search in Google Scholar Back to article
Kircher M, Ihne S, Brumberg J, et al. Detection of cardiac amyloidosis with 18 F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1407-1416. DOI: 10.1007/s00259-019-04290-y
Open DOI Search in Google Scholar Back to article
Cuddy SAM, Bravo PE, Falk RH, et al. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 Jun;13(6):1325-1336. DOI: 10.1016/j.jcmg.2020.02.025
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1072 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 47 - 58

Submitted on: Dec 15, 2021

Accepted on: Jan 17, 2022

Published on: Mar 14, 2022

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

cardiac amyloidosis,

cardiac magnetic resonance imaging,

echocardiography,

PET,

positron emission tomography,

cardiac scintigraphy,

pyrophosphate

© 2022 Jean Michel Saad, Ahmed Ibrahim Ahmed, Dixitha Anugula, Yushui Han, Moath Said Alfawara, Mouaz H. Al-Mallah, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 18 (2022): Issue 2